A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2

Clinical trial NCT01596725 · COMPLETED

Trial details

NCT number: NCT01596725
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza (Pandemic)

Start date: 2012-05-01
Primary completion: 2012-08-01
Enrollment: 333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.